BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 16, 2018
View Archived Issues
Vertex announces positive results for VX-150 in relief of acute pain
Read More
Novel transgelin-2 agonist reduces asthmatic pulmonary resistance in mice
Read More
Overall survival improved with OMS-721 in thrombotic microangiopathy trial
Read More
siCAG/CUG shown as promising new gene therapy for cancer
Read More
Somatic and neurological effects seen with AGT-181 in patients with MPS type I
Read More
First-in-human study of ARO-HBV cleared; ARO-AAT granted U.S. orphan status
Read More
FDA grants fast track designation to Allecra's AAI-101 in fixed-dose combination with cefepime
Read More
TRDN user survey - We want your opinion
Read More
FDA approves Makena subcutaneous atuoinjector
Read More
Shire reviews key development highlights of fourth quarter 2017
Read More
OR51T1 predicts hormone therapy efficacy in men with mHNPC
Read More
Intralytix cleared to begin phase I/IIa trials of bacteriophage preparation
Read More
Nodthera patents new NLRP3 inflammasome inhibitors
Read More
Agios Pharmaceuticals submits NDA for ivosidenib for acute myeloid leukemia
Read More
Results from phase III trial of avelumab in advanced NSCLC
Read More
Accro Bioscience divulges necrosis inhibitors
Read More
Bristol-Myers Squibb Co. presents new TGFBR inhibitors
Read More
CARB-X funds Curza's development of Gram-negative antibiotic program
Read More
Pfizer patents novel C5a1 receptor antagonists
Read More
Sanofi exercises option to license additional multi-specific Nanobodies from Ablynx
Read More
New isochroman derivatives presented by Sunovion Pharmaceuticals
Read More
FDA accepts Shire's sBLA for the use of Cinryze in children
Read More
Miglustat stabilizes ATB-200 in the circulation of Pompe disease patients
Read More
Debiopharm Group acquires minority stake in ABAC Therapeutics
Read More
Xeris completes two phase III studies of its ready-to-use glucagon rescue pen
Read More
Otsuka Pharmaceutical updates pipeline progress of fourth quarter 2017
Read More
Daiichi Sankyo seeks Japanese approval of mirogabalin for peripheral neuropathic pain
Read More
Genethon begins trial of gene therapy for Crigler-Najjar Syndrome
Read More
Miticure approved in Japan for pediatric patients with house dust mite-induced allergic rhinitis
Read More